- Home
- ECX vs AMRN Comparison
ECX vs AMRN Comparison
Compare ECX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECX | AMRN |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United Kingdom | Ireland |
| Employees | 1432 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.7M | 336.1M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ECX | AMRN |
|---|---|---|
| Price | $1.17 | $15.91 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.0M | 94.8K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $819.14 | N/A |
| Revenue Next Year | $32.36 | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $0.88 | $12.96 |
| 52 Week High | $2.70 | $20.90 |
Technical Indicators
Market Signals| Indicator | ECX | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 60.87 |
| Support Level | $1.05 | $13.58 |
| Resistance Level | $1.28 | $17.00 |
| Average True Range (ATR) | 0.11 | 0.79 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 51.35 | 60.66 |
Price Performance
Historical ComparisonAbout ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China. The companies core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.